Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;105:549-556
Published online before print August 13, 2009, doi: 10.1161/CIRCRESAHA.109.195883
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/6/549    most recent
CIRCRESAHA.109.195883v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gorovoy, M.
Right arrow Articles by Voyno-Yasenetskaya, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorovoy, M.
Right arrow Articles by Voyno-Yasenetskaya, T.
Related Collections
Right arrow Animal models of human disease
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2009;105:549.)
© 2009 American Heart Association, Inc.


Integrative Physiology

LIM Kinase 1 Promotes Endothelial Barrier Disruption and Neutrophil Infiltration in Mouse Lungs

Matvey Gorovoy, Jingyan Han, Haiyun Pan, Emily Welch, Radu Neamu, Zhengping Jia, Dan Predescu, Stephen Vogel, Richard D. Minshall, Richard D. Ye, Asrar B. Malik, Tatyana Voyno-Yasenetskaya

From the Department of Pharmacology (M.G., J.H., H.P., E.W., R.N., D.P., S.V., R.M., R.D.Y., A.B.M., T.V.-Y.) and the Center for Lung and Vascular Biology (D.P., S.V., R.M., A.B.M., T.V.-Y.), University of Illinois, Chicago; and the Neuroscience and Mental Health Program (Z.J.), The Hospital for Sick Children, Toronto, Ontario, Canada.

Correspondence to Tatyana Voyno-Yasenetskaya, Department of Pharmacology (MC 868), University of Illinois at Chicago, 909 S Wolcott Ave, Chicago, IL 60612. E-mail tvy{at}uic.edu

Rationale: Disruption of endothelial barrier function and neutrophil-mediated injury are two major mechanisms underlying the pathophysiology of sepsis-induced acute lung injury (ALI). Recently we reported that endotoxin induced activation of RhoA in mice lungs that led to the disruption of endothelial barrier and lung edema formation; however, the molecular mechanism of this phenomenon remained unknown.

Objective: We reasoned that LIMK1, which participates in the regulation of endothelial cell contractility and is activated by RhoA/Rho kinase pathway, could mediate RhoA-dependent disruption of endothelial barrier function in mouse lungs during ALI. And if that is the case, then attenuation of endothelial cell contractility by downregulating LIMK1 may lead to the enhancement of endothelial barrier function, which could protect mice from endotoxin-induced ALI.

Methods and Results: Here we report that LIMK1 deficiency in mice significantly reduced mortality induced by endotoxin. Data showed that lung edema formation, lung microvascular permeability, and neutrophil infiltration into the lungs were suppressed in limk1–/– mice.

Conclusions: We identified that improvement of endothelial barrier function along with impaired neutrophil chemotaxis were the underlying mechanisms that reduced severity of ALI in limk1–/– mice, pointing to a new therapeutic target for diseases associated with acute inflammation of the lungs.


Key Words: LIMK1 • RhoA • endothelial barrier function • inflammation • acute lung injury • neutrophil infiltration • actin cytoskeleton